Much advised Wesana Health in the successful closing of its reverse takeover (RTO) of Debut Diamonds Inc. (n/k/a Wesana Health Holdings Inc.) and its public company listing on the Canadian Securities Exchange (CSE). Wesana Health focuses on the development of psilocybin-based treatments that aim to treat individuals who suffer from traumatic brain injury.
Principals David Brown, Matthew Feery, David Schmidt, and Julia Turk served as advisors to Wesana Health.
In addition to its work in connection with the RTO, the Much team guided Wesana Health as it prepared to be listed on the CSE, which involved, among other things, assistance with the exchange, consolidation, and redesignation of its shares in preparation for the listing. On May 10, the company announced that its shares would commence trading under the ticker symbol "WESA."
"A go-public transaction is a huge moment in any company's journey, and our firm is thrilled to support Wesana Health as it evolves and grows," said Much Chairman David Brown. "Each step better positions the Wesana team to make strides in the areas of patient empowerment and the advancement of psilocybin-based treatments."
In March, Much represented Wesana Health during the successful closing of C$16.1 million in an oversubscribed private placement of subscription receipts through a special purpose financing vehicle ahead of the RTO.